000724369 000__ 05413cam\a2200481Ii\4500
000724369 001__ 724369
000724369 005__ 20230306140530.0
000724369 006__ m\\\\\o\\d\\\\\\\\
000724369 007__ cr\cn\nnnunnun
000724369 008__ 141119t20152015nyua\\\\ob\\\\001\0\eng\d
000724369 019__ $$a899277115$$a907301155
000724369 020__ $$a9781493918812$$qelectronic book
000724369 020__ $$a1493918818$$qelectronic book
000724369 020__ $$z9781493918805
000724369 020__ $$z149391880X
000724369 0247_ $$a10.1007/978-1-4939-1881-2$$2doi
000724369 035__ $$aSP(OCoLC)ocn896116829
000724369 035__ $$aSP(OCoLC)896116829$$z(OCoLC)899277115$$z(OCoLC)907301155
000724369 040__ $$aN$T$$beng$$erda$$epn$$cN$T$$dN$T$$dGW5XE$$dYDXCP$$dCOO$$dOCLCF$$dIDEBK$$dEBLCP$$dCN3GA$$dOCLCO
000724369 049__ $$aISEA
000724369 050_4 $$aRC280.B5
000724369 08204 $$a616.99/462$$223
000724369 24500 $$aManagement of bladder cancer$$h[electronic resource] :$$ba comprehensive text with clinical scenarios /$$cBadrinath R. Konety, Sam S. Chang, editors.
000724369 264_1 $$aNew York :$$bSpringer,$$c[2015]
000724369 264_4 $$c©2015
000724369 300__ $$a1 online resource (xx, 479 pages) :$$billustrations (some color)
000724369 336__ $$atext$$btxt$$2rdacontent
000724369 337__ $$acomputer$$bc$$2rdamedia
000724369 338__ $$aonline resource$$bcr$$2rdacarrier
000724369 504__ $$aIncludes bibliographical references and index.
000724369 5050_ $$aEpidemiology and natural history -- Screening for Bladder Cancer -- Pathology and Staging: Histopathology and Cytopathology -- Pathology and Staging: Genetics and Molecular Biology -- Imaging in Localized and Advanced Bladder Cancer -- New Imaging Techniques in Staging of Urothelial Carcinoma of the Bladder -- Socioeconomic issues and improved quality of care -- Quality of life measures -- Prognostication and risk assessment -- Clinical trials and emerging therapeutic strategies in bladder cancer -- Improved diagnostic techniques -- Clinical scenario: Microscopic hematuria and atypical cytology in a 68 year old man with normal upper tract imaging -- Localized surgical therapy and surveillance -- Clinical Scenario: Initial high grade Ta tumor -- Clinical Scenario: Recurrent Ta tumor -- Clinical Scenario: Rapidly growing, high volume, low grade Ta tumor -- Clinical Scenario: Low grade T1 tumor -- Intravesical therapy -- Clinical Scenario: Initial CIS -- Management of BCG Recurrent Bladder Cancer -- Clinical Scenario: Persistent CIS and HIGH Grade Ta Bladder Cancer after BCG -- Maurizio Brausi -- Clinical Scenario: Presentation and Management of Significant Side Effects from Bacillus Calmette-Guérin Bladder Instillation -- Guideline-based management of non-muscle invasive bladder cancer: comparison of the AUA, EAU, ICUD and NCCN guidelines -- Open Radical Cystectomy -- Robotic cystectomy -- Clinical Scenario: T2 bladder tumor -- Urinary Diversion: Open and robotic techniques -- Chemoradiotherapy -- Clinical Scenario: 53 year-old man with a solitary, 2 cm, high-grade T2 tumor and focal CIS in the bladder dome who wants bladder preservation -- Management of Bladder Cancer, role of chemotherapy and controversies surrounding its application -- Clinical Scenario: Large volume, non metastatic T2 bladder tumor -- The role of pelvic lymphadenectomy at the time of radical cystectomy for bladder cancer -- Clinical Scenario: Unexpected positive nodes at radical cystectomy -- Surveillance and monitoring -- Clinical Scenario: The Role of Perioperative Chemotherapy -- Management of Bladder Cancer with Pelvic Nodal Metastases After Complete Response to Chemotherapy -- Guideline based management muscle-invasive bladder cancer: NCCN, ICUD and EAU.
000724369 506__ $$aAccess limited to authorized users.
000724369 520__ $$aThis book provides a single, comprehensive reference source that incorporates the epidemiology, natural history, and the latest genetic and molecular biological findings of bladder cancer. This book discusses the diagnostic and staging evaluation of both non-muscle invasive and invasive bladder cancer and incorporates the new findings on markers for the diagnosis of bladder cancer. Risk stratified treatment of non-muscle invasive bladder cancer including various approaches to intravesical therapy are reviewed. Current guideline-based approaches to management and new data regarding diagnosis and prognostication of muscle invasive bladder cancer is analyzed and summarized. This book covers the application of chemotherapy for muscle invasive and advanced disease. The evidence-based application of multimodality therapy is highlighted. Gaps in current knowledge and important areas for clinical research are highlighted. Authored by experts in their respective fields, Management of Bladder Cancer: A Comprehensive Text with Clinical Scenarios serves as an easy and complete reference source for clinicians, researchers, individuals in training, allied health professionals and medical students in the fields of Urology, Medical Oncology, Radiation Oncology, Basic and Translational Science and Epidemiology.
000724369 588__ $$aDescription based on online resource; title from PDF title page (viewed December 26, 2014).
000724369 650_0 $$aBladder$$xCancer.
000724369 650_0 $$aBladder$$xCancer$$xTreatment.
000724369 7001_ $$aKonety, Banath R.,$$eeditor.
000724369 7001_ $$aChang, Sam S.$$c(Urologist),$$eeditor.
000724369 77608 $$iPrint version:$$z149391880X$$z9781493918805
000724369 852__ $$bebk
000724369 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-1-4939-1881-2$$zOnline Access$$91397441.1
000724369 909CO $$ooai:library.usi.edu:724369$$pGLOBAL_SET
000724369 980__ $$aEBOOK
000724369 980__ $$aBIB
000724369 982__ $$aEbook
000724369 983__ $$aOnline
000724369 994__ $$a92$$bISE